Nanjing Minova Pharmaceutical Co., Ltd.

Chine

Commandez votre montre hebdomadaire Nanjing Minova Pharmaceutical Co., Ltd.
Quantité totale PI 11
Rang # Quantité totale PI 142 839
Note d'activité PI 2,2/5.0    19
Rang # Activité PI 43 280

Brevets

Marques

2 0
0 0
9 0
0
 
Dernier brevet 2025 - Compound having anti-androgen re...
Premier brevet 2022 - Water-soluble allopregnanolone d...

Derniers inventions, produits et services

2025 Invention Pharmaceutical composition containing xanomeline or salt thereof. Provided in the present inventi...
2024 Invention Pharmaceutical composition comprising allopregnanolone derivative and use thereof. Provided are a...
Invention Salt form and polycrystalline form of allopregnanolone derivative, preparation method therefor, a...
Invention Pharmaceutical composition containing deoxycholic acid and lidocaine, and use thereof. The presen...
2023 Invention Pharmaceutical composition comprising trifarotene and use thereof. A pharmaceutical composition c...
Invention Topical formulation containing pirfenidone and use thereof. A pirfenidone topical formulation is ...
Invention Compound having anti-androgen receptor activity, and use thereof. A compound represented by form...
Invention Compound having anti-androgen receptor activity, and use thereof. maxmax, is good in druggability...
2022 Invention Malate salt of xanomeline derivative, crystalline form a, and preparation method therefor and use...
Invention Water-soluble allopregnanolone derivative, and preparation method therefor and use thereof. A co...
Invention Water-soluble allopregnanolone derivative, and preparation method therefor and use thereof. 24133...